XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 28, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Apr 1, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -27.95%329.21M | -27.95%329.21M | -27.26%432.07M | -43.45%320.01M | -51.87%340.68M | -18.63%456.93M | -18.63%456.93M | -21.09%594.02M | 123.71%565.88M | --707.84M |
-Cash and cash equivalents | -27.95%329.21M | -27.95%329.21M | -27.26%432.07M | -43.45%320.01M | -51.87%340.68M | -18.63%456.93M | -18.63%456.93M | -21.09%594.02M | 123.71%565.88M | --707.84M |
Receivables | 2.69%534.93M | 2.69%534.93M | -0.16%530.11M | 3.74%509.8M | -13.21%477.57M | -10.66%520.93M | -10.66%520.93M | -2.01%530.93M | 16.96%491.43M | --550.28M |
-Accounts receivable | 8.68%497.28M | 8.68%497.28M | 8.66%503.17M | 4.85%457.11M | -17.00%424.49M | -14.67%457.57M | -14.67%457.57M | -10.91%463.08M | 14.35%435.97M | --511.44M |
-Notes receivable | -80.26%1.16M | -80.26%1.16M | ---- | ---- | ---- | 26.24%5.9M | 26.24%5.9M | ---- | ---- | ---- |
-Taxes receivable | -37.99%39.61M | -37.99%39.61M | -60.29%26.94M | -5.00%52.69M | 36.64%53.08M | 34.15%63.88M | 34.15%63.88M | 208.06%67.85M | 42.55%55.46M | --38.85M |
-Recievables adjustments allowances | 51.09%-3.14M | 51.09%-3.14M | ---- | ---- | ---- | -17.80%-6.41M | -17.80%-6.41M | ---- | ---- | ---- |
Inventory | 5.11%638.08M | 5.11%638.08M | -2.89%643.03M | -14.45%633.37M | -24.70%625.67M | -25.31%607.05M | -25.31%607.05M | -19.60%662.17M | 26.82%740.35M | --830.94M |
Restricted cash | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | -99.95%1.14M | --1.19M |
Other current assets | -4.48%108.57M | -4.48%108.57M | -7.51%102.87M | -8.82%107.41M | 3.93%123.53M | -12.09%113.66M | -12.09%113.66M | 8.88%111.22M | -8.69%117.8M | --118.86M |
Total current assets | -18.26%1.62B | -18.26%1.62B | -41.73%1.72B | -46.88%1.58B | -35.88%1.58B | -15.32%1.98B | -15.32%1.98B | 32.46%2.94B | -23.42%2.97B | --2.46B |
Non current assets | ||||||||||
Net PPE | 10.20%1.71B | 10.20%1.71B | 9.21%1.63B | 9.20%1.58B | 0.16%1.56B | 4.04%1.55B | 4.04%1.55B | 0.73%1.49B | 70.49%1.45B | --1.56B |
-Gross PPE | 12.51%2.76B | 12.51%2.76B | 12.44%2.65B | 12.53%2.56B | 5.46%2.51B | 8.77%2.46B | 8.77%2.46B | -9.22%2.36B | 47.41%2.28B | --2.38B |
-Accumulated depreciation | -16.44%-1.06B | -16.44%-1.06B | -17.96%-1.03B | -18.31%-983.07M | -15.52%-948.01M | -17.92%-908.09M | -17.92%-908.09M | 22.35%-869.95M | -19.30%-830.91M | ---820.64M |
Goodwill and other intangible assets | -3.68%5.04B | -3.68%5.04B | -4.46%5.09B | -4.88%5.13B | -13.59%5.18B | -16.36%5.23B | -16.36%5.23B | -16.51%5.32B | 390.89%5.39B | --5.99B |
-Goodwill | -0.06%3.94B | -0.06%3.94B | -0.19%3.95B | -0.66%3.94B | -7.14%3.94B | -10.49%3.95B | -10.49%3.95B | -10.24%3.95B | 402.86%3.97B | --4.25B |
-Other intangible assets | -14.84%1.09B | -14.84%1.09B | -16.79%1.14B | -16.65%1.18B | -29.33%1.23B | -30.40%1.28B | -30.40%1.28B | -30.53%1.37B | 360.29%1.42B | --1.74B |
Non current deferred assets | -60.35%12.46M | -60.35%12.46M | -32.67%20.34M | -63.92%24.06M | -17.12%24.7M | 8.89%31.43M | 8.89%31.43M | 62.10%30.21M | 151.17%66.68M | --29.8M |
Other non current assets | -12.43%24.14M | -12.43%24.14M | -35.19%24.98M | -29.84%28.09M | -11.26%30.71M | -23.95%27.56M | -23.95%27.56M | 0.42%38.54M | 232.66%40.03M | --34.6M |
Total non current assets | -0.83%6.78B | -0.83%6.78B | -1.79%6.76B | -2.66%6.76B | -10.79%6.79B | -12.41%6.84B | -12.41%6.84B | -13.02%6.88B | 249.85%6.94B | --7.61B |
Total assets | -4.74%8.39B | -4.74%8.39B | -13.76%8.47B | -15.90%8.34B | -16.91%8.36B | -13.08%8.81B | -13.08%8.81B | -3.05%9.82B | 69.13%9.91B | --10.07B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 29.38%273.79M | 29.38%273.79M | 7.52%218.43M | -6.73%204M | -25.41%202.21M | -21.78%211.61M | -21.78%211.61M | -11.88%203.15M | 12.19%218.72M | --271.08M |
-accounts payable | 44.00%193.26M | 44.00%193.26M | 24.74%174.19M | 7.13%141.58M | -21.55%131.15M | -22.19%134.21M | -22.19%134.21M | -25.61%139.64M | -9.75%132.16M | --167.18M |
-Total tax payable | 4.04%80.53M | 4.04%80.53M | -30.35%44.24M | -27.90%62.42M | -31.61%71.06M | -21.06%77.4M | -21.06%77.4M | 48.29%63.52M | 78.40%86.56M | --103.9M |
Current accrued expenses | -11.65%250.17M | -11.65%250.17M | -11.27%302.34M | -24.56%235.2M | -21.49%266.84M | -13.88%283.16M | -13.88%283.16M | -12.79%340.74M | 57.33%311.78M | --339.88M |
Current debt and capital lease obligation | ---- | ---- | --65M | ---- | ---- | ---- | ---- | ---- | ---- | --159.05M |
-Current debt | ---- | ---- | --65M | ---- | ---- | ---- | ---- | ---- | ---- | --159.05M |
Other current liabilities | -93.69%1.21M | -93.69%1.21M | -99.34%925K | -99.43%662K | -91.97%933K | 80.72%19.22M | 80.72%19.22M | --139.27M | --115.78M | --11.62M |
Current liabilities | 2.18%525.18M | 2.18%525.18M | -14.12%586.69M | -31.94%439.86M | -39.87%469.98M | -32.54%514M | -32.54%514M | -18.77%683.16M | 64.39%646.29M | --781.62M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -12.76%4.05B | -12.76%4.05B | -24.80%4.13B | -24.59%4.19B | -25.67%4.25B | -18.68%4.65B | -18.68%4.65B | -3.74%5.5B | 60.29%5.56B | --5.71B |
-Long term debt | -13.02%3.98B | -13.02%3.98B | -25.16%4.06B | -24.94%4.12B | -25.94%4.17B | -18.74%4.58B | -18.74%4.58B | -3.59%5.43B | 61.11%5.49B | --5.63B |
-Long term capital lease obligation | 4.60%72.16M | 4.60%72.16M | 2.34%73.02M | 3.45%71.8M | -6.02%72.66M | -14.53%68.99M | -14.53%68.99M | -13.90%71.35M | 13.98%69.41M | --77.32M |
Non current deferred liabilities | -63.09%70.19M | -63.09%70.19M | -56.07%101.78M | -51.33%146.52M | -52.32%166.77M | -51.39%190.14M | -51.39%190.14M | -43.69%231.7M | 502.17%301.07M | --349.76M |
Employee benefits | 1.40%54.48M | 1.40%54.48M | 30.12%58.07M | 3.35%53.79M | -5.86%52.2M | -0.66%53.73M | -0.66%53.73M | -17.43%44.63M | 46.07%52.05M | --55.45M |
Total non current liabilities | -14.56%4.18B | -14.56%4.18B | -25.63%4.29B | -25.70%4.39B | -27.02%4.46B | -20.60%4.89B | -20.60%4.89B | -6.52%5.77B | 66.36%5.91B | --6.12B |
Total liabilities | -12.97%4.7B | -12.97%4.7B | -24.41%4.88B | -26.32%4.83B | -28.47%4.93B | -21.92%5.4B | -21.92%5.4B | -7.99%6.46B | 66.16%6.56B | --6.9B |
Shareholders'equity | ||||||||||
Share capital | 0.46%1.51M | 0.46%1.51M | 0.53%1.51M | 0.47%1.51M | 0.73%1.51M | 0.87%1.51M | 0.87%1.51M | 0.80%1.5M | 10.35%1.5M | --1.5M |
-common stock | 0.46%1.51M | 0.46%1.51M | 0.53%1.51M | 0.47%1.51M | 0.73%1.51M | 0.87%1.51M | 0.87%1.51M | 0.80%1.5M | 10.35%1.5M | --1.5M |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | 20.15%1.38B | 20.15%1.38B | 14.88%1.3B | 11.13%1.23B | 27.35%1.18B | 11.67%1.15B | 11.67%1.15B | 14.16%1.13B | 3.08%1.11B | --928.13M |
Paid-in capital | 3.47%2.39B | 3.47%2.39B | 3.38%2.36B | 2.67%2.34B | 2.80%2.31B | 4.54%2.31B | 4.54%2.31B | 4.24%2.28B | 155.01%2.27B | --2.24B |
Less: Treasury stock | 0.00%7.11M | 0.00%7.11M | 0.00%7.11M | 0.00%7.11M | 0.00%7.11M | 0.00%7.11M | 0.00%7.11M | 0.00%7.11M | 0.00%7.11M | --7.11M |
Gains losses not affecting retained earnings | -67.98%-72.12M | -67.98%-72.12M | -53.61%-59.65M | -124.17%-61.82M | -7,615.30%-54.04M | -227.80%-42.93M | -227.80%-42.93M | 32.90%-38.83M | 46.09%-27.58M | --719K |
Total stockholders'equity | 8.30%3.69B | 8.30%3.69B | 6.66%3.59B | 4.48%3.5B | 8.27%3.43B | 5.92%3.41B | 5.92%3.41B | 8.09%3.37B | 75.26%3.35B | --3.17B |
Total equity | 8.30%3.69B | 8.30%3.69B | 6.66%3.59B | 4.48%3.5B | 8.27%3.43B | 5.92%3.41B | 5.92%3.41B | 8.09%3.37B | 75.26%3.35B | --3.17B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |